eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
Share:
Send email
Share:
Original paper

Is immunotherapy protective against steroid intake in patients with polysensitized allergic rhinitis and/or asthma?

Feridun Gürlek
1

  1. Department of Allergy and Immunology, University of Health Sciences, Bursa Training and Research Hospital, Bursa, Türkiye
Alergologia Polska – Polish Journal of Allergology
DOI: https://doi.org/10.5114/pja.2024.144860
Online publish date: 2024/11/08
Article file
- is immunotherapy.pdf  [0.26 MB]
Get citation
 
PlumX metrics:
 
1. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. AWHO position paper. J Allergy Clin Immunol 1998; 102: 558-62.
2. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63: 8-160.
3. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-75.
4. Marogna M, Spadolini I, Massolo A, et al. Long-lasting effects of sublingual immunotherapy according to its duration: a 15 year prospective study. J Allergy Clin Immunol 2010; 126: 969-75.
5. Olgaç M, Demir S, Ünal D, et al. Role of premedication to prevent reactions in cluster immunotherapy. Pol J Allergol 2023; 10: 180-6.
6. Stefanowicz A, Podsiedlik A, Poloczek A, et al. Food allergies, searching for rescue therapy: a literatüre review. Pol J Allergol 2023; 10: 265-70.
7. Calderon MA, Cox L, Casale TB, et al. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol 2012; 129: 929-34.
8. GINA Executive Committee. Global Initiative for Asthma; global strategy for asthma management and prevention. National Heart, Lung and Blood Institute, National Institute of Health, Bethesda, MD (2011). Available from:www.who.int/respiratory/asthma/GINA WR 2006 copyright[1].pdf
9. Kim SH, Shin SY, Lee KH, et al. Long-term effects of specific allergen immunotherapy against house dust mites in polysensitized patients with allergic rhinitis. Allergy Asthma Immunol Res 2014; 6: 535-40.
10. Bahceciler NN, Galip N, Babayigit A. Steroid sparing effect of sublingual immunotherapy: real life study in mono/polisensitized children with asthma. Immunotherapy 2017; 9: 1263-69.
11. Zielen S, Kardos P, Madonini E. Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial. J Allergy Clin Immunol 2010; 126: 942-9.
12. Rhyou HI, Nam YH. Efficacy of allergen ımmunotherapy for allergic asthma in real world practice. Allergy Asthma Immunol Res 2020; 12: 99-109.
13. Unsel M, Babayigit A, Bahceciler N. Maintained disease control and steroid-sparing effect of subcutaneous immunotherapy in allergic rhinitis and asthma. Asian Pac J Allergy Immunol 2022 Mar 12. doi: 10.12932/AP-030921-1222.
14. Blumberga G, Groes L, Haugaard L, Dahl R. Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics. Allergy 2006; 61: 843-8.
15. Mosbech H. Tolerability and efficacy of house dust mite AIT. Allergy 2011; 66: 55-6.
16. Compalati E, Passalacqua G, Bonini M, Canonica GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009; 64: 1570-9.
17. Marogna M, Braidi C, Bruno ME, et al. The contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: a real-life randomised trial. Allergol Immunopathol 2013; 41: 216-24.
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.


Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.